![Andrew Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 561 365 $ in data 30/06/2026
Andrew Cheng is currently Chairman, President & Chief Executive Officer at Avere Therapeutics, Inc. Dr. Cheng serves as Independent Director at Vera Therapeutics, Inc. since 2017.
Dr. Cheng is Director at Boys & Girls Clubs of Metro Los Angeles.
Dr. Cheng is Independent Director at TCGX Acquisition Corp.
starting in 2026.
Formerly, Dr. Cheng was President, Chief Executive Officer & Director at Akero Therapeutics, Inc. from 2018 to 2025.
Dr. Cheng was Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022.
Dr. Cheng was Director at Syntimmune, Inc. Dr. Cheng was Director at Global Virus Network.
Dr. Cheng was Non-Executive Director at MorphoSys AG from 2022 to 2024.
Dr. Cheng was Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. in 2018.
Dr. Cheng completed undergraduate studies at The Johns Hopkins University in 1988.
Dr. Cheng earned a doctorate from Columbia University College of Physicians & Surgeons in 1996.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/05/2026 | 17.488 ( 0,02% ) | 561 365 $ | 31/07/2026 | |
1,39% | 04/08/2026 | 30.000 ( 1,39% ) | 0 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2017 |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Amministratore Delegato | 09/12/2025 |
| MORPHOSYS AG | Direttore/Membro del Consiglio | 06/06/2024 |
| ARBUTUS BIOPHARMA CORPORATION | Direttore/Membro del Consiglio | 25/05/2022 |
| GILEAD SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 07/09/2018 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Boys & Girls Clubs of Metro Los Angeles
Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
